ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Bush Tax Cut, Economic Slowdown Turn Up Heat On Budget Competition.

July 20, 2001

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

NCI Cooperative Group, Cancer Center Trials Listed

February 27, 2009

Spending Bill Could Give 15% Raise To NIH; Gimmicks Complicate Picture, Veto Looms

November 5, 1999

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013